Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO12604 | Phakellia dendyi | Species | Bubaridae | Eukaryota | Byron Strait, Papua New Guinea | 2003 |
PMID[18327911] |
|
NPO33061 | pseudaxinella sp. | Species | Axinellidae | Eukaryota | Republic of Palau | 1979 |
PMID[18327911] |
|
NPO7079 | Stylissa massa | Species | Axinellidae | Eukaryota | Philippines |
PMID[11784156] |
||
NPO24195 | Stylissa carteri | Species | Axinellidae | Eukaryota | indopacific |
PMID[9917317] |
||
NPO7079 | Stylissa massa | Species | Axinellidae | Eukaryota |
PMID[23684893] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 7870.46 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 9885.53 | nM | 15921415 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 12647.36 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 63973.48 | nM | 12193037 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 25118.86 | nM | 25625705 | |
NPT591 | Individual Protein | Glycogen synthase kinase-3 beta | Homo sapiens | IC50 | = | 10 | nM | 19874044 |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 70145.53 | nM | 25581396 | |
NPT168 | Cell Line | P388 | Mus musculus | Activity | = | 2.4 | ug/ml | 22418279 |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 39994.47 | nM | 18177008 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 100000 | nM | 3404149 | |
NPT1431 | Individual Protein | Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens | IC50 | = | 7000 | nM | 26287401 |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 55335.01 | nM | 22182501 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 38636.7 | nM | 20452770 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 13001.7 | nM | 17962024 | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 13001.7 | nM | 20106559 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 39627.8 | nM | DrugMatrix in vitro pharmacology data | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 16106.46 | nM | 22182927 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 5584.7 | nM | 23142671 | |
NPT3814 | Protein Complex | Cyclin-dependent kinase 2/cyclin A | Homo sapiens | IC50 | = | 70 | nM | Open TG-GATES in vivo data: Hematology |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 15631.48 | nM | DrugMatrix in vivo data: Pathology | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 86297.85 | nM | 15646539 | |
NPT2 | Others | Unspecified | IC50 | = | 0.2 | ug/ml | 12088425 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 2716.44 | nM | 17685651 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 56623.93 | nM | 23501116 | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 43351.09 | nM | 19711971 | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 11912.42 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 30408.85 | nM | DrugMatrix in vitro pharmacology data | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 17498.47 | nM | PubChem BioAssay data set | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 48528.85 | nM | 24387625 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 6123.5 | nM | 10.6019/CHEMBL1201861 | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 100000 | nM | 17067146 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 1599.56 | nM | 22439591 | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 45919.8 | nM | 24462176 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 79799.47 | nM | 9834177 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 40926.07 | nM | 23819871 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 52722.99 | nM | 24063582 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 34593.94 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 8933.05 | nM | 17854154 | |
NPT168 | Cell Line | P388 | Mus musculus | GI50 | 3971.92 | nM | 22483395 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 21777.1 | nM | 20073490 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 34833.73 | nM | 12608854 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 12618.28 | nM | 17432904 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 48194.78 | nM | 24949913 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 1901.08 | nM | 7760077 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 3854.78 | nM | 17067151 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 1655.77 | nM | 25629555 | |
NPT3944 | Protein Complex | Cyclin-dependent kinase 2/cyclin E1 | Homo sapiens | IC50 | = | 40 | nM | PubChem BioAssay data set |
NPT1561 | Protein Complex | Cyclin-dependent kinase 1/cyclin B1 | Homo sapiens | IC50 | = | 22 | nM | PubChem BioAssay data set |
NPT591 | Individual Protein | Glycogen synthase kinase-3 beta | Homo sapiens | IC50 | = | 10 | nM | PubChem BioAssay data set |
NPT1680 | Individual Protein | Serine/threonine-protein kinase Chk2 | Homo sapiens | IC50 | = | 42 | nM | PubChem BioAssay data set |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 3019.95 | nM | 24175613 | |
NPT2 | Others | Unspecified | IC50 | = | 10 | nM | 21856049 | |
NPT1680 | Individual Protein | Serine/threonine-protein kinase Chk2 | Homo sapiens | IC50 | = | 42 | nM | 18579374 |
NPT3266 | Individual Protein | Casein kinase I delta | Homo sapiens | IC50 | = | 35 | nM | 16562830 |
NPT1598 | Individual Protein | Casein kinase II alpha | Homo sapiens | IC50 | = | 7000 | nM | 16562830 |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | IC50 | = | 6 | nM | 16562830 |
NPT182 | Individual Protein | Protein kinase C alpha | Homo sapiens | IC50 | = | 700 | nM | 16562830 |
NPT760 | Individual Protein | Protein kinase C beta | Homo sapiens | IC50 | = | 1200 | nM | 26259802 |
NPT1608 | Individual Protein | Serine/threonine-protein kinase Chk1 | Homo sapiens | IC50 | = | 1950 | nM | 26259802 |
NPT1570 | Protein Complex | Cyclin-dependent kinase 1/cyclin B | Homo sapiens | IC50 | = | 22 | nM | 541686 |
NPT15 | Cell Line | Jurkat | Homo sapiens | IC50 | = | 2410 | nM | 17850214 |
NPT6640 | Individual Protein | NF-kappa-B-repressing factor | Homo sapiens | Inhibition | = | 46 | % | 17850214 |
NPT1970 | Cell Line | THP-1 | Homo sapiens | IC50 | = | 1360 | nM | 17850214 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | = | 1610 | nM | 17850214 |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 45081.67 | nM | 21534539 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 4102.04 | nM | 21035332 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 65614.53 | nM | 17067173 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 31915.38 | nM | 19620329 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 4285.49 | nM | 19456120 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 29716.66 | nM | 18955526 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 5571.86 | nM | 19506058 | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 85506.67 | nM | DrugMatrix in vitro pharmacology data | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 5093.31 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 4886.52 | nM | 10.1007/s00044-013-0567-7 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 4295.36 | nM | 20594858 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 100000 | nM | 11325244 | |
NPT491 | Individual Protein | Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens | IC50 | = | 6 | nM | 10075775 |
NPT2 | Others | Unspecified | IC50 | = | 40 | nM | 26341134 | |
NPT2 | Others | Unspecified | IC50 | = | 22 | nM | 21504848 | |
NPT1608 | Individual Protein | Serine/threonine-protein kinase Chk1 | Homo sapiens | IC50 | = | 1900 | nM | 18507474 |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 974.99 | nM | 10924160 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 10351.42 | nM | 16643031 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 18323.14 | nM | 23206866 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 29716.66 | nM | 22582991 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 45289.76 | nM | 9514009 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 33884.42 | nM | 17988094 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 100000 | nM | 20038128 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 9616.12 | nM | 25856683 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 67764.15 | nM | 12088420 | |
NPT2 | Others | Unspecified | IC50 | = | 30 | nM | 12828488 | |
NPT3240 | Individual Protein | Cyclin-dependent kinase 5 | Homo sapiens | IC50 | = | 30 | nM | 12828488 |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | IC50 | = | 9 | nM | DrugMatrix in vitro pharmacology data |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 52119.47 | nM | DrugMatrix in vitro pharmacology data | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 40831.94 | nM | 10.1007/s00044-007-9010-2 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 97051 | nM | 23305918 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 2546.83 | nM | 24389510 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 4655.86 | nM | 24864039 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 44258.84 | nM | PubChem BioAssay data set | |
NPT591 | Individual Protein | Glycogen synthase kinase-3 beta | Homo sapiens | IC50 | = | 10 | nM | 24689881 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 2904.02 | nM | 26042639 | |
NPT591 | Individual Protein | Glycogen synthase kinase-3 beta | Homo sapiens | IC50 | = | 10 | nM | 12828466 |
NPT1509 | Protein Complex | Cyclin-dependent kinase 5/CDK5 activator 1 | Homo sapiens | IC50 | = | 28 | nM | 12828466 |
NPT1570 | Protein Complex | Cyclin-dependent kinase 1/cyclin B | Homo sapiens | IC50 | = | 22 | nM | 21856049 |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 11324 | nM | 17844994 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 40550.85 | nM | PubChem BioAssay data set | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 37583.74 | nM | 16854088 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 27542.29 | nM | 12662095 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 3451.44 | nM | 19860383 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 5688.53 | nM | 23398362 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 57942.87 | nM | 15787444 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 80909.59 | nM | 25978960 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 57543.99 | nM | 10924172 | |
NPT114 | Cell Line | LoVo | Homo sapiens | IC50 | = | 710 | nM | 12662097 |
NPT490 | Protein Family | Serine/threonine-protein kinase RAF and Dual specificity mitogen-activated protein kinase kinase 1 (Raf/MEK) | Homo sapiens | IC50 | = | 6 | nM | 12662097 |
NPT491 | Individual Protein | Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens | IC50 | = | 2500 | nM | 12662097 |
NPT492 | Cell Line | Caco-2 | Homo sapiens | IC50 | > | 7799 | nM | 12662097 |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 10739.89 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 7211.07 | nM | 19938815 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 4275.63 | nM | 17371815 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 8830.8 | nM | 18519713 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 4570.88 | nM | 18591275 | |
NPT552 | Cell Line | P388/ADR | Mus musculus | GI50 | 7277.8 | nM | DrugMatrix in vitro pharmacology data | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 13427.65 | nM | 23352268 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 100000 | nM | 27025343 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 5597.58 | nM | 25510639 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 71285.3 | nM | 10346948 | |
NPT591 | Individual Protein | Glycogen synthase kinase-3 beta | Homo sapiens | IC50 | = | 10 | nM | DrugMatrix in vivo data: Biochemistry |
NPT738 | Cell Line | SN12K1 | Homo sapiens | GI50 | 12274.39 | nM | 25554367 | |
NPT1431 | Individual Protein | Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens | IC50 | = | 150 | nM | 10395505 |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vitro pharmacology data | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 9120.11 | nM | DrugMatrix in vitro pharmacology data | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 7655.97 | nM | 19674906 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 7430.19 | nM | 18183025 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 23713.74 | nM | 22037378 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 48752.85 | nM | 10.6019/CHEMBL1201861 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 42461.96 | nM | 10.6019/CHEMBL1201861 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 39084.09 | nM | 18077363 | |
NPT591 | Individual Protein | Glycogen synthase kinase-3 beta | Homo sapiens | IC50 | = | 10 | nM | DrugMatrix in vitro pharmacology data |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 26424.09 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 80723.5 | nM | 26854381 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 100000 | nM | 17418454 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 7744.62 | nM | 17223562 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 29174.27 | nM | 18362191 | |
NPT4886 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 7 | Homo sapiens | Inhibition | = | 20 | % | 18426901 |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 18578.04 | nM | 16472241 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 40831.94 | nM | DrugMatrix in vitro pharmacology data | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 19543.39 | nM | 10.1007/s00044-011-9655-8 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 2904.02 | nM | 26034885 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 15275.66 | nM | 16919944 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 10471.29 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 7161.43 | nM | 8289059 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 38370.72 | nM | 24144848 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 19678.86 | nM | 17665951 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 13772.09 | nM | 17665951 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 70307.23 | nM | 10579870 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 27164.39 | nM | 19349520 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 303.39 | nM | 19721074 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 2432.2 | nM | 22194678 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 100000 | nM | 22916954 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC184932 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC472861 |
0.9568 | High Similarity | NPC37268 |
0.9387 | High Similarity | NPC271927 |
0.9141 | High Similarity | NPC474696 |
0.875 | High Similarity | NPC469976 |
0.8563 | High Similarity | NPC73687 |
0.848 | Intermediate Similarity | NPC80528 |
0.8452 | Intermediate Similarity | NPC206148 |
0.8402 | Intermediate Similarity | NPC2414 |
0.8129 | Intermediate Similarity | NPC476418 |
0.8043 | Intermediate Similarity | NPC19342 |
0.8011 | Intermediate Similarity | NPC111566 |
0.8011 | Intermediate Similarity | NPC63571 |
0.8 | Intermediate Similarity | NPC54214 |
0.7967 | Intermediate Similarity | NPC310633 |
0.791 | Intermediate Similarity | NPC97106 |
0.7865 | Intermediate Similarity | NPC136441 |
0.7842 | Intermediate Similarity | NPC9635 |
0.7831 | Intermediate Similarity | NPC19696 |
0.7831 | Intermediate Similarity | NPC136957 |
0.7789 | Intermediate Similarity | NPC469717 |
0.7766 | Intermediate Similarity | NPC48117 |
0.7766 | Intermediate Similarity | NPC329765 |
0.7766 | Intermediate Similarity | NPC476526 |
0.7725 | Intermediate Similarity | NPC174281 |
0.7725 | Intermediate Similarity | NPC475286 |
0.7705 | Intermediate Similarity | NPC469814 |
0.7701 | Intermediate Similarity | NPC476413 |
0.7697 | Intermediate Similarity | NPC476421 |
0.7697 | Intermediate Similarity | NPC28096 |
0.7697 | Intermediate Similarity | NPC227489 |
0.7679 | Intermediate Similarity | NPC260041 |
0.766 | Intermediate Similarity | NPC476414 |
0.7602 | Intermediate Similarity | NPC476524 |
0.7598 | Intermediate Similarity | NPC226835 |
0.7572 | Intermediate Similarity | NPC474236 |
0.7571 | Intermediate Similarity | NPC233380 |
0.7546 | Intermediate Similarity | NPC20021 |
0.7527 | Intermediate Similarity | NPC46022 |
0.7527 | Intermediate Similarity | NPC112489 |
0.75 | Intermediate Similarity | NPC150592 |
0.7486 | Intermediate Similarity | NPC27296 |
0.7436 | Intermediate Similarity | NPC469716 |
0.7433 | Intermediate Similarity | NPC476527 |
0.7424 | Intermediate Similarity | NPC476525 |
0.7344 | Intermediate Similarity | NPC46811 |
0.7287 | Intermediate Similarity | NPC476423 |
0.7278 | Intermediate Similarity | NPC474383 |
0.7222 | Intermediate Similarity | NPC306160 |
0.7207 | Intermediate Similarity | NPC473706 |
0.7143 | Intermediate Similarity | NPC474389 |
0.7127 | Intermediate Similarity | NPC162268 |
0.7108 | Intermediate Similarity | NPC469715 |
0.7102 | Intermediate Similarity | NPC52110 |
0.7074 | Intermediate Similarity | NPC40530 |
0.7074 | Intermediate Similarity | NPC314281 |
0.7026 | Intermediate Similarity | NPC188821 |
0.7026 | Intermediate Similarity | NPC474180 |
0.6938 | Remote Similarity | NPC475736 |
0.6927 | Remote Similarity | NPC474258 |
0.6906 | Remote Similarity | NPC475870 |
0.6856 | Remote Similarity | NPC473946 |
0.685 | Remote Similarity | NPC477004 |
0.6837 | Remote Similarity | NPC210123 |
0.6813 | Remote Similarity | NPC212742 |
0.6789 | Remote Similarity | NPC473380 |
0.6789 | Remote Similarity | NPC240088 |
0.6774 | Remote Similarity | NPC49217 |
0.6772 | Remote Similarity | NPC186068 |
0.6758 | Remote Similarity | NPC142688 |
0.6753 | Remote Similarity | NPC133003 |
0.6751 | Remote Similarity | NPC243716 |
0.6732 | Remote Similarity | NPC471191 |
0.6714 | Remote Similarity | NPC50562 |
0.6714 | Remote Similarity | NPC474195 |
0.6699 | Remote Similarity | NPC473218 |
0.6699 | Remote Similarity | NPC470702 |
0.6685 | Remote Similarity | NPC109158 |
0.6685 | Remote Similarity | NPC472260 |
0.6683 | Remote Similarity | NPC473376 |
0.6682 | Remote Similarity | NPC67658 |
0.6667 | Remote Similarity | NPC247987 |
0.6667 | Remote Similarity | NPC265710 |
0.6667 | Remote Similarity | NPC470703 |
0.6667 | Remote Similarity | NPC11126 |
0.6651 | Remote Similarity | NPC156003 |
0.6633 | Remote Similarity | NPC477166 |
0.6633 | Remote Similarity | NPC304187 |
0.6632 | Remote Similarity | NPC16659 |
0.6632 | Remote Similarity | NPC91179 |
0.663 | Remote Similarity | NPC299594 |
0.663 | Remote Similarity | NPC471655 |
0.6618 | Remote Similarity | NPC471944 |
0.6616 | Remote Similarity | NPC324091 |
0.6615 | Remote Similarity | NPC477003 |
0.6615 | Remote Similarity | NPC21429 |
0.6612 | Remote Similarity | NPC33229 |
0.659 | Remote Similarity | NPC474196 |
0.6582 | Remote Similarity | NPC311282 |
0.6579 | Remote Similarity | NPC302647 |
0.6575 | Remote Similarity | NPC13432 |
0.6564 | Remote Similarity | NPC470205 |
0.6557 | Remote Similarity | NPC232798 |
0.6552 | Remote Similarity | NPC291517 |
0.655 | Remote Similarity | NPC66642 |
0.6545 | Remote Similarity | NPC161861 |
0.654 | Remote Similarity | NPC471193 |
0.654 | Remote Similarity | NPC471194 |
0.6538 | Remote Similarity | NPC270918 |
0.6535 | Remote Similarity | NPC77061 |
0.6531 | Remote Similarity | NPC228835 |
0.652 | Remote Similarity | NPC474318 |
0.652 | Remote Similarity | NPC475914 |
0.652 | Remote Similarity | NPC220797 |
0.652 | Remote Similarity | NPC201266 |
0.652 | Remote Similarity | NPC268744 |
0.652 | Remote Similarity | NPC153123 |
0.6517 | Remote Similarity | NPC101130 |
0.6517 | Remote Similarity | NPC129412 |
0.6517 | Remote Similarity | NPC58268 |
0.6517 | Remote Similarity | NPC114033 |
0.6515 | Remote Similarity | NPC17059 |
0.6505 | Remote Similarity | NPC474492 |
0.6489 | Remote Similarity | NPC271734 |
0.6489 | Remote Similarity | NPC274981 |
0.6488 | Remote Similarity | NPC77241 |
0.6488 | Remote Similarity | NPC166209 |
0.6488 | Remote Similarity | NPC269203 |
0.6488 | Remote Similarity | NPC13456 |
0.6482 | Remote Similarity | NPC473628 |
0.648 | Remote Similarity | NPC270834 |
0.6477 | Remote Similarity | NPC151635 |
0.6465 | Remote Similarity | NPC94752 |
0.6465 | Remote Similarity | NPC17273 |
0.6465 | Remote Similarity | NPC141612 |
0.6465 | Remote Similarity | NPC135601 |
0.6457 | Remote Similarity | NPC23215 |
0.6453 | Remote Similarity | NPC79356 |
0.6453 | Remote Similarity | NPC179701 |
0.6453 | Remote Similarity | NPC102592 |
0.645 | Remote Similarity | NPC475874 |
0.6443 | Remote Similarity | NPC183662 |
0.6443 | Remote Similarity | NPC217372 |
0.6443 | Remote Similarity | NPC15573 |
0.644 | Remote Similarity | NPC471943 |
0.6439 | Remote Similarity | NPC237414 |
0.6435 | Remote Similarity | NPC168209 |
0.6432 | Remote Similarity | NPC54744 |
0.6432 | Remote Similarity | NPC282247 |
0.6422 | Remote Similarity | NPC243633 |
0.6422 | Remote Similarity | NPC262898 |
0.6422 | Remote Similarity | NPC175150 |
0.6421 | Remote Similarity | NPC109447 |
0.642 | Remote Similarity | NPC98156 |
0.642 | Remote Similarity | NPC138596 |
0.642 | Remote Similarity | NPC195704 |
0.642 | Remote Similarity | NPC292434 |
0.642 | Remote Similarity | NPC200397 |
0.642 | Remote Similarity | NPC167200 |
0.642 | Remote Similarity | NPC14448 |
0.642 | Remote Similarity | NPC64661 |
0.6418 | Remote Similarity | NPC476460 |
0.6415 | Remote Similarity | NPC72956 |
0.641 | Remote Similarity | NPC219336 |
0.6409 | Remote Similarity | NPC204141 |
0.6409 | Remote Similarity | NPC470440 |
0.6406 | Remote Similarity | NPC272174 |
0.64 | Remote Similarity | NPC209917 |
0.6394 | Remote Similarity | NPC317701 |
0.6386 | Remote Similarity | NPC473342 |
0.6386 | Remote Similarity | NPC477167 |
0.6385 | Remote Similarity | NPC153980 |
0.6385 | Remote Similarity | NPC6865 |
0.6383 | Remote Similarity | NPC470680 |
0.6383 | Remote Similarity | NPC100104 |
0.6378 | Remote Similarity | NPC88110 |
0.6378 | Remote Similarity | NPC477042 |
0.6372 | Remote Similarity | NPC470732 |
0.6369 | Remote Similarity | NPC59839 |
0.6369 | Remote Similarity | NPC48171 |
0.6369 | Remote Similarity | NPC286529 |
0.6369 | Remote Similarity | NPC169308 |
0.6369 | Remote Similarity | NPC77582 |
0.6369 | Remote Similarity | NPC209281 |
0.6369 | Remote Similarity | NPC129753 |
0.6369 | Remote Similarity | NPC12831 |
0.6369 | Remote Similarity | NPC244087 |
0.6369 | Remote Similarity | NPC74928 |
0.6369 | Remote Similarity | NPC3698 |
0.6369 | Remote Similarity | NPC97230 |
0.6369 | Remote Similarity | NPC205604 |
0.6369 | Remote Similarity | NPC302717 |
0.6368 | Remote Similarity | NPC470323 |
0.6364 | Remote Similarity | NPC110158 |
0.6364 | Remote Similarity | NPC213914 |
0.6351 | Remote Similarity | NPC116555 |
0.6344 | Remote Similarity | NPC298288 |
0.6344 | Remote Similarity | NPC209362 |
0.6341 | Remote Similarity | NPC141454 |
0.634 | Remote Similarity | NPC469529 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC184932 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6859 | Remote Similarity | NPD3178 | Discontinued |
0.6837 | Remote Similarity | NPD5592 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD7459 | Phase 2 |
0.6788 | Remote Similarity | NPD1096 | Discontinued |
0.6784 | Remote Similarity | NPD2289 | Phase 3 |
0.6784 | Remote Similarity | NPD2290 | Phase 3 |
0.6684 | Remote Similarity | NPD1783 | Clinical (unspecified phase) |
0.66 | Remote Similarity | NPD460 | Discontinued |
0.6591 | Remote Similarity | NPD569 | Clinical (unspecified phase) |
0.6574 | Remote Similarity | NPD5001 | Clinical (unspecified phase) |
0.6564 | Remote Similarity | NPD3319 | Phase 1 |
0.6564 | Remote Similarity | NPD3320 | Approved |
0.6564 | Remote Similarity | NPD3318 | Approved |
0.6538 | Remote Similarity | NPD8493 | Clinical (unspecified phase) |
0.6538 | Remote Similarity | NPD1506 | Discontinued |
0.6507 | Remote Similarity | NPD2443 | Approved |
0.6507 | Remote Similarity | NPD2442 | Approved |
0.6476 | Remote Similarity | NPD1600 | Suspended |
0.6462 | Remote Similarity | NPD7656 | Approved |
0.6462 | Remote Similarity | NPD7657 | Approved |
0.6459 | Remote Similarity | NPD6328 | Clinical (unspecified phase) |
0.6456 | Remote Similarity | NPD7817 | Phase 1 |
0.645 | Remote Similarity | NPD5685 | Approved |
0.645 | Remote Similarity | NPD5686 | Approved |
0.6432 | Remote Similarity | NPD6141 | Clinical (unspecified phase) |
0.6422 | Remote Similarity | NPD1952 | Discontinued |
0.6402 | Remote Similarity | NPD7970 | Approved |
0.6402 | Remote Similarity | NPD7971 | Clinical (unspecified phase) |
0.6382 | Remote Similarity | NPD5820 | Clinical (unspecified phase) |
0.6359 | Remote Similarity | NPD5199 | Approved |
0.6359 | Remote Similarity | NPD5198 | Approved |
0.6344 | Remote Similarity | NPD3360 | Clinical (unspecified phase) |
0.634 | Remote Similarity | NPD4883 | Approved |
0.6324 | Remote Similarity | NPD9343 | Clinical (unspecified phase) |
0.6321 | Remote Similarity | NPD2408 | Discontinued |
0.6308 | Remote Similarity | NPD3916 | Clinical (unspecified phase) |
0.6308 | Remote Similarity | NPD3917 | Approved |
0.6308 | Remote Similarity | NPD3918 | Approved |
0.6303 | Remote Similarity | NPD3411 | Phase 2 |
0.6303 | Remote Similarity | NPD3410 | Approved |
0.6296 | Remote Similarity | NPD3353 | Approved |
0.6293 | Remote Similarity | NPD6449 | Clinical (unspecified phase) |
0.6291 | Remote Similarity | NPD7809 | Clinical (unspecified phase) |
0.6286 | Remote Similarity | NPD6288 | Clinical (unspecified phase) |
0.628 | Remote Similarity | NPD2405 | Phase 3 |
0.6269 | Remote Similarity | NPD2009 | Clinical (unspecified phase) |
0.6263 | Remote Similarity | NPD3990 | Phase 3 |
0.6262 | Remote Similarity | NPD3915 | Approved |
0.6256 | Remote Similarity | NPD4559 | Clinical (unspecified phase) |
0.6256 | Remote Similarity | NPD4736 | Clinical (unspecified phase) |
0.6244 | Remote Similarity | NPD7619 | Phase 3 |
0.6244 | Remote Similarity | NPD7618 | Phase 3 |
0.6244 | Remote Similarity | NPD3968 | Approved |
0.6244 | Remote Similarity | NPD7704 | Clinical (unspecified phase) |
0.6243 | Remote Similarity | NPD1592 | Phase 3 |
0.6233 | Remote Similarity | NPD6165 | Phase 2 |
0.6233 | Remote Similarity | NPD6164 | Phase 2 |
0.6232 | Remote Similarity | NPD1982 | Phase 1 |
0.623 | Remote Similarity | NPD5138 | Approved |
0.623 | Remote Similarity | NPD5140 | Approved |
0.6225 | Remote Similarity | NPD1896 | Approved |
0.6223 | Remote Similarity | NPD276 | Clinical (unspecified phase) |
0.622 | Remote Similarity | NPD7903 | Clinical (unspecified phase) |
0.622 | Remote Similarity | NPD5017 | Discontinued |
0.6219 | Remote Similarity | NPD706 | Phase 1 |
0.6218 | Remote Similarity | NPD2844 | Phase 3 |
0.6212 | Remote Similarity | NPD3989 | Phase 3 |
0.6197 | Remote Similarity | NPD6376 | Discontinued |
0.6193 | Remote Similarity | NPD1591 | Approved |
0.6193 | Remote Similarity | NPD5643 | Phase 2 |
0.6188 | Remote Similarity | NPD3486 | Clinical (unspecified phase) |
0.6186 | Remote Similarity | NPD8013 | Clinical (unspecified phase) |
0.6184 | Remote Similarity | NPD2880 | Discontinued |
0.6184 | Remote Similarity | NPD6664 | Approved |
0.6183 | Remote Similarity | NPD4463 | Approved |
0.6183 | Remote Similarity | NPD4462 | Approved |
0.6179 | Remote Similarity | NPD3967 | Approved |
0.6179 | Remote Similarity | NPD2008 | Discontinued |
0.6176 | Remote Similarity | NPD6180 | Clinical (unspecified phase) |
0.6176 | Remote Similarity | NPD1658 | Discontinued |
0.6173 | Remote Similarity | NPD482 | Approved |
0.6173 | Remote Similarity | NPD3522 | Approved |
0.6171 | Remote Similarity | NPD7717 | Approved |
0.6171 | Remote Similarity | NPD6752 | Phase 1 |
0.6171 | Remote Similarity | NPD6753 | Phase 1 |
0.6171 | Remote Similarity | NPD7716 | Approved |
0.6167 | Remote Similarity | NPD2323 | Clinical (unspecified phase) |
0.6164 | Remote Similarity | NPD6578 | Clinical (unspecified phase) |
0.6162 | Remote Similarity | NPD2590 | Clinical (unspecified phase) |
0.6158 | Remote Similarity | NPD1284 | Clinical (unspecified phase) |
0.6154 | Remote Similarity | NPD7204 | Clinical (unspecified phase) |
0.6154 | Remote Similarity | NPD3834 | Clinical (unspecified phase) |
0.6154 | Remote Similarity | NPD465 | Clinical (unspecified phase) |
0.615 | Remote Similarity | NPD5965 | Clinical (unspecified phase) |
0.6143 | Remote Similarity | NPD7727 | Phase 2 |
0.6142 | Remote Similarity | NPD749 | Clinical (unspecified phase) |
0.6139 | Remote Similarity | NPD7026 | Phase 2 |
0.6135 | Remote Similarity | NPD1871 | Approved |
0.6121 | Remote Similarity | NPD4959 | Approved |
0.6121 | Remote Similarity | NPD4960 | Approved |
0.6111 | Remote Similarity | NPD4092 | Approved |
0.6109 | Remote Similarity | NPD6210 | Phase 3 |
0.6108 | Remote Similarity | NPD3246 | Discontinued |
0.6103 | Remote Similarity | NPD1575 | Approved |
0.6103 | Remote Similarity | NPD1573 | Approved |
0.6093 | Remote Similarity | NPD5510 | Approved |
0.6091 | Remote Similarity | NPD4541 | Clinical (unspecified phase) |
0.608 | Remote Similarity | NPD3999 | Approved |
0.608 | Remote Similarity | NPD3997 | Approved |
0.608 | Remote Similarity | NPD3078 | Approved |
0.608 | Remote Similarity | NPD3998 | Approved |
0.608 | Remote Similarity | NPD3076 | Approved |
0.608 | Remote Similarity | NPD3077 | Approved |
0.608 | Remote Similarity | NPD3079 | Approved |
0.6077 | Remote Similarity | NPD2947 | Clinical (unspecified phase) |
0.6075 | Remote Similarity | NPD6838 | Clinical (unspecified phase) |
0.6073 | Remote Similarity | NPD2214 | Approved |
0.6073 | Remote Similarity | NPD2213 | Approved |
0.6066 | Remote Similarity | NPD4464 | Clinical (unspecified phase) |
0.6066 | Remote Similarity | NPD5020 | Approved |
0.6065 | Remote Similarity | NPD7998 | Clinical (unspecified phase) |
0.6062 | Remote Similarity | NPD1631 | Approved |
0.6061 | Remote Similarity | NPD4091 | Approved |
0.6061 | Remote Similarity | NPD2367 | Phase 2 |
0.6059 | Remote Similarity | NPD5809 | Phase 3 |
0.6059 | Remote Similarity | NPD4426 | Clinical (unspecified phase) |
0.6056 | Remote Similarity | NPD8115 | Approved |
0.6056 | Remote Similarity | NPD8114 | Approved |
0.605 | Remote Similarity | NPD5146 | Suspended |
0.6049 | Remote Similarity | NPD3870 | Clinical (unspecified phase) |
0.6049 | Remote Similarity | NPD3871 | Clinical (unspecified phase) |
0.6049 | Remote Similarity | NPD1043 | Phase 3 |
0.6048 | Remote Similarity | NPD7621 | Clinical (unspecified phase) |
0.6047 | Remote Similarity | NPD7232 | Discontinued |
0.6039 | Remote Similarity | NPD2004 | Clinical (unspecified phase) |
0.6038 | Remote Similarity | NPD6268 | Phase 1 |
0.6038 | Remote Similarity | NPD6269 | Clinical (unspecified phase) |
0.6037 | Remote Similarity | NPD4863 | Approved |
0.6036 | Remote Similarity | NPD1996 | Discontinued |
0.6036 | Remote Similarity | NPD6579 | Phase 2 |
0.603 | Remote Similarity | NPD3991 | Approved |
0.603 | Remote Similarity | NPD3994 | Approved |
0.603 | Remote Similarity | NPD3992 | Approved |
0.603 | Remote Similarity | NPD3995 | Approved |
0.603 | Remote Similarity | NPD3993 | Approved |
0.603 | Remote Similarity | NPD3996 | Approved |
0.6029 | Remote Similarity | NPD3961 | Discontinued |
0.6029 | Remote Similarity | NPD5446 | Phase 2 |
0.6027 | Remote Similarity | NPD3757 | Clinical (unspecified phase) |
0.6019 | Remote Similarity | NPD3856 | Clinical (unspecified phase) |
0.6009 | Remote Similarity | NPD2411 | Approved |
0.5991 | Remote Similarity | NPD6837 | Clinical (unspecified phase) |
0.599 | Remote Similarity | NPD2095 | Phase 2 |
0.599 | Remote Similarity | NPD3347 | Clinical (unspecified phase) |
0.599 | Remote Similarity | NPD2092 | Phase 2 |
0.599 | Remote Similarity | NPD6665 | Discontinued |
0.599 | Remote Similarity | NPD2094 | Phase 2 |
0.599 | Remote Similarity | NPD1630 | Approved |
0.599 | Remote Similarity | NPD5728 | Clinical (unspecified phase) |
0.5981 | Remote Similarity | NPD8098 | Approved |
0.5981 | Remote Similarity | NPD3247 | Clinical (unspecified phase) |
0.598 | Remote Similarity | NPD4940 | Approved |
0.598 | Remote Similarity | NPD3315 | Phase 3 |
0.5973 | Remote Similarity | NPD2787 | Clinical (unspecified phase) |
0.597 | Remote Similarity | NPD1618 | Phase 2 |
0.5969 | Remote Similarity | NPD6855 | Clinical (unspecified phase) |
0.5969 | Remote Similarity | NPD5069 | Clinical (unspecified phase) |
0.5968 | Remote Similarity | NPD175 | Clinical (unspecified phase) |
0.5966 | Remote Similarity | NPD1781 | Discontinued |
0.5961 | Remote Similarity | NPD721 | Approved |
0.5961 | Remote Similarity | NPD2091 | Phase 2 |
0.5961 | Remote Similarity | NPD3607 | Clinical (unspecified phase) |
0.5961 | Remote Similarity | NPD2096 | Phase 2 |
0.5953 | Remote Similarity | NPD7568 | Phase 1 |
0.5947 | Remote Similarity | NPD2603 | Clinical (unspecified phase) |
0.5936 | Remote Similarity | NPD8096 | Phase 3 |
0.5936 | Remote Similarity | NPD8093 | Discontinued |
0.5936 | Remote Similarity | NPD8097 | Phase 3 |
0.5934 | Remote Similarity | NPD201 | Phase 2 |
0.5934 | Remote Similarity | NPD200 | Phase 2 |
0.5933 | Remote Similarity | NPD7406 | Phase 2 |
0.5931 | Remote Similarity | NPD2814 | Clinical (unspecified phase) |
0.593 | Remote Similarity | NPD7662 | Clinical (unspecified phase) |
0.5926 | Remote Similarity | NPD4415 | Approved |
0.5922 | Remote Similarity | NPD5016 | Approved |
0.5922 | Remote Similarity | NPD1657 | Approved |
0.5921 | Remote Similarity | NPD1580 | Clinical (unspecified phase) |
0.5921 | Remote Similarity | NPD1579 | Discontinued |
0.592 | Remote Similarity | NPD8386 | Phase 2 |
0.5916 | Remote Similarity | NPD3405 | Phase 3 |
0.5916 | Remote Similarity | NPD2061 | Approved |
0.5915 | Remote Similarity | NPD3891 | Phase 2 |
0.5915 | Remote Similarity | NPD3890 | Phase 2 |
0.5913 | Remote Similarity | NPD7098 | Clinical (unspecified phase) |
0.5913 | Remote Similarity | NPD6263 | Clinical (unspecified phase) |
0.5913 | Remote Similarity | NPD4922 | Phase 2 |
0.5912 | Remote Similarity | NPD272 | Approved |
0.5909 | Remote Similarity | NPD2363 | Discontinued |
0.5909 | Remote Similarity | NPD2823 | Clinical (unspecified phase) |
0.5909 | Remote Similarity | NPD8094 | Discontinued |
PubChem CID   | 3035462 |
ChEMBL   | CHEMBL361708 |
ZINC   |
Molecular Weight:   | 323.00 |
ALogP:   | -0.9034 |
MLogP:   | 1.79 |
XLogP:   | 1.425 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 113.36 |
# H-Bond Aceptor:   | 7 |
# H-Bond Donor:   | 5 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |